BioChem Pharma Takes 30 Percent Stake in $100 Million Newly Created GeneChem Technologies Venture Fund L.P.LAVAL, QUEBEC--(BUSINESS WIRE)--March 13, 1997-- BIOCHEM(ME, TSE See Tokyo Stock Exchange. TSE 1. See Tokyo Stock Exchange (TSE). 2. See Toronto Stock Exchange (TSE). BCH BCH Beach BCH Banco Central de Honduras BCH Boot Console Handler BCH Boulder Community Hospital (Boulder, CO, USA) BCH Broadcast Channel BCH Belfast City Hospital BCH Banco Central-Hispano ., NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on BCHXF.) BioChem Pharma Inc. announced today that it is investing CDN (Content Delivery Network) A system of distributed content on a large intranet or the public Internet in which copies of content are replicated and cached throughout the network. $30 million in GeneChem Technologies Venture Fund L.P., a venture capital fund sponsored by BioChem Pharma's newly created subsidiary, GeneChem Financial Corporation. The Fund, with committed capital of CDN$100 million from Canadian investors, will invest in academic projects and early-stage private or public companies, in the area of genomics and related technologies, for human application. Investments will be made in Canada Made in Canada may also mean Country of origin. Made in Canada is a Canadian television situation comedy which aired on the CBC from 1998 to 2003. In the United States, France, Australia and Latin America, the show was syndicated as The Industry. , but the Fund will also invest in the U.S. and other countries. BioChem is partnering with a group of financial investors including the Caisse de depot et Placement du Quebec, le Fonds de Solidarite des travailleurs du Quebec (FTQ FTQ Fédération des Travailleurs du Québec FTQ First Time Quality FTQ Fetch Target Queue FTQ Fond de Solidarité de La Fédération des Travailleurs du Québec ), the National Bank of Canada This article is about a commercial bank. For Canada's central bank, see Bank of Canada. National Bank of Canada (Banque Nationale du Canada) TSX: NA is the sixth largest bank in Canada, and so is one of the Big Six banks. , the Royal Bank Capital Corporation, and the retirement plans of the STCUM STCUM Société de Transport de la Communauté Urbaine de Montréal (French: Montreal Urban Community Transport Commission) STCUM Société des Transports de la Communauté Urbaine de Montréal (the Montreal Urban Community's transportation commission). Understanding Genes - Revolutionizing Medicine A revolution in the knowledge of the human body at its most fundamental level, the human genome, is underway. Collectively, the genetic code of an organism is known as its genome. Thus, genomics is the study and identification of the function of genes. It is thought that a majority of human disease stems from a genetic component. Genomics will therefore facilitate the task of designing and developing targeted therapies for unmet medical needs. "BioChem is highly enthusiastic about this initiative," said Dr. Gervais Dionne, Executive Vice-President, Research and Development, at BioChem Pharma. "We feel that genomics represents the focal point for the discovery of innovative medicines in the future. Our investment in this fund will broaden our access to scientific breakthroughs in this field," he added. BioChem Pharma is one of the limited partners in the Fund which is managed by GeneChem Management Inc., a wholly owned indirect subsidiary of BioChem Pharma. The Fund will operate for a term of ten years. "We are very encouraged by the development of the fund which was oversubscribed Refers to connecting more users to a system than can be fully supported if all of them were using it at the same time. Networks and servers are almost always designed with some amount of oversubscription, counting on the fact that everybody does not need the service simultaneously. ," stated Francois Legault, Executive Vice-President of BioChem Pharma. "It will enable BioChem Pharma and its partners to significantly leverage their financial resources when investing in this field," he concluded. BioChem Pharma, celebrating its tenth anniversary, is an international biopharmaceutical company dedicated to the research, development and commercialization of innovative products for the prevention, detection and treatment of human diseases. The Company lists its common shares on the Montreal and Toronto exchanges (BCH) and the NASDAQ stock market Nasdaq stock market The first electronic stock market listing over 5000 companies. The Nasdaq stock market comprises two separate markets, namely the Nasdaq National Market, which trades large, active securities and the Nasdaq Smallcap Market that trades emerging growth companies. (BCHXF). BioChem Pharma news releases and other company information can be found on the World Wide Web at: http://www.biochem-pharma.com . This press release contains forward-looking statements which reflect the company's current expectation regarding future events. The forward-looking statements involve risks and uncertainties. Actual events could differ materially from those projected herein and depend on a number of factors: the success of genomics in facilitating, or the extent to which it will facilitate, the discovery and development of new drugs; the applicability of the discoveries made through genomics; the strong competitive environment related to the rapid evolution of technology in this field; the economic value of such discoveries and what the development of the knowledge of the human body will tell us. CONTACT: BioChem Pharma Inc. Christine Lennon, 514/978-7771 corpcom@biochem-pharma.com 
reflects some of information of Biochem.
|
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion